ACHV stock: buy or sell?
June 26th, 2019
Achieve Life Sciences, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients.
Should I buy ACHV stock?You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. That's why is so important to choose your own trading plan that fits your character as inversor. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
Currently, Achieve Life Sciences stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Achieve Life Sciences stock a buy?
Banks and financial institutions post stock ratings everyday.At Stocks2.com, we gathered 2 ratings published for ACHV stock in the last 30 days.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-6-11||LADENBURG THALM/SH SH||Positive||Buy|
ACHV stock analysis
Achieve Life Sciences shares slipped -2.42% to $2.02 today.
Achieve Life Sciences shares slipped -2.42% to $2.02 today. In the last 44 days when SMA100d and SMA200d crossed up, ACHV price slipped $-2.11 per share (-51.09%). ACHV marked a lower low and a lower high in the short term, defining a downward trend. Climbing above $2.89 would break this short term down trend and open possibilities for reversing this situation.
Achieve Life Sciences closed this week at $2.02 and plummed a hair-raising -12.93%. Counting this, it's been 4 sliding weeks in a row, loosing $-2.19 (-56.74%). Late May ACHV rocketed an exceptional 8.31% in just one week.
Achieve Life Sciences finally dropped under the support line and now is sliding further looking for new supports. Since mid June, when ACHV stock price broke down the 40-weeks moving avarage line, it slid $-1.64 per share (-44.81%). Stocks under the 40-weeks moving average line are usually not recommended for average traders. Since SMA20w and SMA40w crossed up late April, ACHV price slid a -53.56%.
ACHV stock price history
ACHV stock went public on October 13th, 2000 with a price of $1,670.531. Since then, ACHV stock sliced a -99.90%, with a yearly average of -5.60%.
1: Adjusted price after possible price splits or reverse-splits.
ACHV stock historical price chart
ACHV stock reached 52-week highs at $6.10, and all-time highs 2005-10-18 with a price of 9979.2.
ACHV stock price target is $13.00How much a stock will be priced tomorrow or next week is quite unpredictable However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. You should not follow the analysts' ACHV stock price predictions in the hope that they will be met as they may be wrong and not met. For the last 30 days we found 2 price predictions for Achieve Life Sciences stock:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-6-11||LADENBURG THALM/SH SH||Reiterates||$12.00||$20.00||66.7%|
Financials and fundamental analysis
Earnings date and Earnings per ShareAfter presenting its last earnings report on March, Achieve Life Sciences collapsed a bloodcurdling -17.55%. As soon as we get its actual EPS from the earnings report, we will update this review.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2015, last anual turnover report draw a hair-raising slide of -72.13% to $5.06 M dollars. When comparing 2016 vs 2015, aligned with this, profit margin (that is, the net income divided by revenues) plummed a -305.13% to -397.65%.
|2013||$30 M||-||$-31.85 M-106.6%||-|
|2014||$27 M||-9.25%||$-26.24 M-96.8%||-17.61%|
|2015||$18 M||-33.03%||$-16.80 M-92.5%||-35.97%|
|2016||$5.06 M||-72.13%||$-20.13 M-397.6%||19.81%|
Quarterly financial resultsReported quarter earnings marked $-3.64 million with a profit margin of . Profit margin remained stable a 0.00% compared to previous quarter when profit margin was inf%. When comparing revenues to same quarter last year, Achieve Life Sciences sales marked a neutral movement and remained stable a nan%. Looking back to recent quarterly results, Achieve Life Sciences posted 7 negative quarters in a row.
Achieve Life Sciences ownershipWhen you are planning to buy a stock, it's always worth to check its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Achieve Life Sciences, 4.97% of all outstanding shares are owned by its staff.
In case of Achieve Life Sciences stock, 28.42% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for ACHV stock account 0.00%, no big difference from last month.
For a better understanding, the following table shows ownership data compared to other related stocks:
|Market cap||$13.9 M|
|Total shares||6.9 M|
|Float shares||5.0 M|
|- Institutional holdings (%)||28.4%|
|- Insider holdings (%)||5.0%|
|Shares in short selling||0.0%|
|Wednesday, June 26th, 2019|
|Day range||$1.92 - $2.10|
|Average true range||$0.32|
|50d mov avg||$3.60|
|100d mov avg||$3.12|
|200d mov avg||$2.51|
Achieve Life Sciences performancePerformance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. In the following table, we compare Achieve Life Sciences performance to :
|ACHVAchieve Life Scie...||-37.46%||68.33%||-46.56%|